14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 81 days ( 0 % )
Last Price $0.0722 0 %
High/ Low $0.0722 - $0.0722 0%
Chg 7 Days N/A $0.0722 $0.0722
Chg 30 Days N/A $0.0722 $0.0722
Chg 12 mos -96.35 % $1.98 $0.0722
Trend - 3 mos 7.14 % Width: 243.98 %
Trend - 12 mos -76.13 % Width: 163.40 %
Pred. range - 3 mos $0.0235 - $0.0808 -67.47 % - 11.91 %
Pred. range - 12 mos N/A - $0.176 -100.00 % - 144.07 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Jun 08, 2023 - 114 days
Long MA avg 12 mos Sell Feb 23, 2023 - 187 days
Short/Long MA avg 12 mos Sell Mar 08, 2023 - 178 days
Pivot Short Sell Nov 17, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About 9 Meters Biopharma, Inc.

9 Meters Biopharma. 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide... NMTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT